Sawai Pharmaceutical Co. Ltd.’s $1.05 billion acquisition of Upsher?Smith Laboratories, Inc.

Sawai Pharmaceutical Co. Ltd. has signed an agreement to acquire the generic pharmaceuticals business of Upsher?Smith Laboratories, Inc., from its parent, ACOVA Inc. Upsher-Smith is a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here